Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06052293
Status:
COMPLETED
Last Update Posted:
2024-01-05
First Post:
2023-08-09
Brief Title:
Phase 1 Study to Assess Safety and Efficacy of ANG003
Sponsor:
Anagram Therapeutics Inc
Organization:
Anagram Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-06-24
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-09
First Submit QC Date:
September 18 2023
Study First Post Date:
2023-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-12
Last Update Post Date:
2024-01-05
Last Update Post Date Type:
ACTUAL